|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A01N 43/04 | (2006.01) |
| A61K 9/68 | (2006.01) | ||
| A61K 31/70 | (2006.01) | ||
| C07H 21/02 | (2006.01) | ||
| C07H 21/04 | (2006.01) |
| (11) | Patento numeris | 2901856 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15153954.1 |
| Europos patento paraiškos padavimo data | 2005-06-15 | |
| (97) | Europos patento paraiškos paskelbimo data | 2015-08-05 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2017-08-09 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 579985 P | 2004-06-15 | US | |
| 599362 P | 2004-08-06 | US |
| (72) |
Agrawal, Sudhir, US
Kandimalla, Ekambar, US
Yu, Dong, US
|
| (73) |
Idera Pharmaceuticals, Inc.,
345 Vassar Street, Cambridge, MA 02139,
US
|
| (54) | Immunostimulatory oligonucleotide multimers |
| Immunostimulatory oligonucleotide multimers |